Investigating the role of a specific microRNA in brain tumors
Epigenetics and 3D Structure of miR-10b/HoxD Locus in the Brain and Malignant Glioma
This study is looking at how a tiny molecule called microRNA-10b affects the growth of glioblastoma, a tough type of brain cancer, to find new ways to help treat patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10892994 on NIH RePORTER |
What this research studies
This research focuses on glioblastoma, a highly aggressive brain tumor, and explores the role of microRNA-10b in its development and progression. The study aims to understand how this microRNA is activated in gliomas and its impact on tumor growth and survival. By examining the three-dimensional structure of the miR-10b locus in the brain, researchers hope to uncover the epigenetic changes that contribute to glioblastoma. This could lead to new therapeutic strategies targeting miR-10b for treating patients with this challenging cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with glioblastoma or other types of malignant gliomas.
Not a fit: Patients with non-malignant brain tumors or those without glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that target glioblastoma more effectively, potentially improving survival rates for patients.
How similar studies have performed: Previous research has shown promise in targeting microRNAs for cancer treatment, suggesting that this approach could be beneficial.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Krichevsky, Anna M. — Brigham and Women's Hospital
- Study coordinator: Krichevsky, Anna M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.